In this episode, we look at a life sciences instrumentation company in the genome analysis space called Bionano Genomics (BNGO.Q). The company develops and markets the Saphyr system, a platform used for ultra-sensitive and ultra-specific structural variation detection. This Optical Genome Mapping (OGM) platform can detect these large Structural Variations responsible for genetic diseases and can reveal them at sensitivities as high as 99%, with false-positive rates below 2%. But how well has the Saphyr worked BNGO so far? We look at their tech, financial statements and stock price. Tune in!
Latest News
Alaska Energy Metals (AEMC.V): Another great deal the deal guys burned, but look behind the curtain
A Portuguese feast: EuroPacific Metals (EUP.V) digs in on a copper and gold smorgasbord
Plurilock Security (PLUR.V) seals $900k deal to Canadian Federal Government Agency
Top 5 Gainers and Losers: THRM.V, AGC.CN, FWZ.V
Zefiro Methane (ZEFI.E) has three ways to get paid taking over orphaned oil wells
Top 5 Gainers and Losers: RPX.V, HIGH.V, TML.TO
